AAAAI 2022: Real-World Analysis Confirms Benefits of Lanadelumab for Hereditary Angioedema Prophylaxis
Patient-reported outcomes indicate an improvement in quality of life as well
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.